Skip to main content

Clinical Trial of Human Botulism Immune Globulin

  • Chapter
Botulinum and Tetanus Neurotoxins

Abstract

A major theme of this conference is that botulinum toxin, nature’s most poisonous poison,1 has now been “tamed” and has acquired the distinction of becoming, through the work of Scott2 and Schantz,3 the first bacterial toxin to serve as a medicine for the betterment of humanity. So in this historic and felicitous context, it appears to be my unwelcome responsibility to remind this conference that botulinum toxin remains very much an adversary for certain select groups of patients, most notably, infants.4

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lammana C. The most poisonous poison. Science 1959; 130: 763–772.

    Article  Google Scholar 

  2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044–1049.

    PubMed  CAS  Google Scholar 

  3. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80–99.

    PubMed  CAS  Google Scholar 

  4. Amon SS. Infant botulism. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, third edition. Philadelphia: WB Saunders, 1992:1095–1102 (ch. 107).

    Google Scholar 

  5. Amon SS, Midura TF, Clay SA, Wood RM, Chin J. Infant botulism: epidemiological, clinical, and laboratory aspects. JAMA 1977; 237: 1946–1951.

    Article  Google Scholar 

  6. Wilcke BW Jr, Midura TF, Amon SS. Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis 1980; 141: 419–423.

    Article  PubMed  Google Scholar 

  7. Mills DC, Amon SS. The large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis 1987; 156: 997–998.

    Article  PubMed  CAS  Google Scholar 

  8. Centers for Disease Control. Summary of notifiable diseases, United States, 1990. Morbid Mortal Wkly Rept 1991; 39 (53): 56.

    Google Scholar 

  9. Chia JK, Clark JB, Ryan CA, Pollack M. Botulism in an adult associated with foodbome intestinal infection with Clostridium botulinum. N Engl J Med 1986; 315: 239–241.

    Article  PubMed  CAS  Google Scholar 

  10. Freedman M, Armstrong RM, Killian JM, Boland D. Botulism in a patient with jejunoileal bypass. Ann Neurol 1986; 20: 641–643.

    Article  PubMed  CAS  Google Scholar 

  11. Sonnabend WF, Sonnabend OA, Grundler P, Ketz E. Intestinal toxicoinfection by Clostridium botulinum type Fin an adult. Lancet 1987; 1: 357–362.

    Article  PubMed  CAS  Google Scholar 

  12. McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol 1988; 26: 1052–1054.

    PubMed  CAS  Google Scholar 

  13. McCroskey LM, Hatheway CL, Woodruff BA, Greenberg JA, Jurgenson P. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J Clin Microbiol 1991; 29: 2618–2620.

    PubMed  CAS  Google Scholar 

  14. Pickett J, Berg B, Chaplin E, Brunstetter-Shafer M. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 1976; 295: 770–772.

    Article  PubMed  CAS  Google Scholar 

  15. Midura TF, Amon SS. Infant botulism: identification of Clostridium botulinum and its toxins in faeces. Lancet 1976; 2: 934–936.

    Article  PubMed  CAS  Google Scholar 

  16. Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 1980; 69: 567–569.

    Article  PubMed  CAS  Google Scholar 

  17. Lewis GE Jr, Metzger JF. Botulism immune plasma (human). Lancet 1978; 312: 634–635.

    Article  Google Scholar 

  18. Lewis GE Jr, Metzger JF. Studies on the prophylaxis and treatment of botulism. In: Eaker D, Wadstrom T, eds. Textbook of Natural Toxins. New York: Pergamon Press, 1980: 601–606

    Google Scholar 

  19. Ember L. Chemical weapons: plan proposed to destroy Iraqi arms. Chem Eng News 1991; 69: 6.

    Google Scholar 

  20. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodbome botulism. Am J Med 1984; 76: 794–798.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Arnon, S.S. (1993). Clinical Trial of Human Botulism Immune Globulin. In: DasGupta, B.R. (eds) Botulinum and Tetanus Neurotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9542-4_53

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9542-4_53

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9544-8

  • Online ISBN: 978-1-4757-9542-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics